Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole + Naproxen vs Celecoxib for NSAID-Associated Ulcers in OA
NCT00175032Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of lansoprazole in gastroduodenal ulcer (2 arms), sponsored by Takeda. Primary endpoint: Gastroduodenal ulcers at final visit at 12 weeks. Started Jul 2003; status: completed.
02
Drugs
lansoprazole
03
Conditions
gastroduodenal ulcer
Beyond the preview
Go deeper on NCT00175032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175032.